Margaret Patrick has been writing for Market Realist since 2014. She covers hospital, health insurance, biotech, pharmaceutical, and medical device stocks.
In its latest 13F filing, Berkshire Hathaway (BRK.A) disclosed an 11% increase in its stake in Amazon (AMZN) at the end of the second quarter.
On July 26, the Wall Street Journal first reported Amazon’s deal with demand-side platforms the Trade Desk and Dataxu TouchPoint.
Reports note that Amazon (AMZN) is in late-stage discussions related to acquiring up to 10% in Future Retail, a leading brick-and-mortar retailer in India.
Facebook may be fined billions of euros in the EU. Ireland’s Data Protection Commission brought 11 cases against the social media giant based on the GDPR.
In a move to leverage India's growing travel industry, Amazon is offering customers cash back on domestic flight bookings from August 12 to August 20.
Amazon has also been gradually increasing its revenue exposure to the digital advertising business—and there's huge opportunity in the space.
Yesterday, Amarin announced its receipt of a notice from the FDA about the agency’s plans for an advisory committee meeting on November 14.
After nine days of decline, Amazon stock finally recovered 1.29% to $1,787.83 on August 6. Yesterday, it rose 0.31% to close at $1,793.40.
Insulet (PODD) stock has risen 19.27% today to $140.65, soaring in response to the company's strong second-quarter results yesterday.
Regeneron (REGN) reported its Q2 earnings results before the markets opened. REGN reported revenues of $1.93 billion, a YoY increase of 20%.